RECRUITING

HOPE Intervention for Fitness

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

We will test the HOPE intervention on changing behavior of people to exercise more (take more steps each day).

Official Title

Harnessing Online Peer Education For Fitness in People With Type II Diabetes

Quick Facts

Study Start:2025-10-21
Study Completion:2026-05-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07114822

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years or older
  2. * Living in the US
  3. * Self-report diagnosis of type II diabetes
  4. * Has an app to track step count
  1. * On insulin or an injectable weight loss drug

Contacts and Locations

Study Contact

Staff Research Associate
CONTACT
(949) 522-9165
hopestudy@hs.uci.edu

Study Locations (Sites)

UC Irvine
Irvine, California, 92617
United States

Collaborators and Investigators

Sponsor: University of California, Irvine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-10-21
Study Completion Date2026-05-01

Study Record Updates

Study Start Date2025-10-21
Study Completion Date2026-05-01

Terms related to this study

Additional Relevant MeSH Terms

  • Diabetes Mellitus Type 2